Abstract: Previous results from our laboratory have demonstrated that equine infectious anemia virus displays structural variations in its surface glycoproteins and RNA genome during passage and chronic infections in experimentally infected Shetland ponies (Montelaro et al., J. Biol. Chem. 259:10539-10544, 1984; Payne et al., J. Gen. Virol. 65:1395-1399, 1984). The present study was undertaken to obtain an antigenic and biochemical characterization of equine infectious anemia virus isolates recovered from an experimentally infected pony during sequential disease episodes, each separated by intervals of only 4 to 8 weeks. The virus isolates could be distinguished antigenically by neutralization assays with serum from the infected pony and by Western blot analysis with a monoclonal antibody against the major surface glycoprotein gp90, thus demonstrating that novel antigenic variants of equine infectious anemia virus predominate during each clinical episode. The respective virion glycoproteins displayed different electrophoretic mobilities on sodium dodecyl sulfate-polyacrylamide gels, indicating structural variation. Tryptic peptide and glycopeptide maps of the viral proteins of each virus isolate revealed biochemical alterations involving amino acid sequence and glycosylation patterns in the virion surface glycoproteins gp90 and gp45. In contrast, no structural variation was observed in the internal viral proteins pp15, p26, and p9 from any of the four virus isolates. Oligonucleotide mapping experiments revealed similar but unique RNase T1-resistant oligonucleotide fingerprints of the RNA genomes of each of the virus isolates. Localization of altered oligonucleotides for one virus isolate placed two of three unique oligonucleotides within the predicted env gene region of the genome, perhaps correlating with the structural variation observed in the envelope glycoproteins. Thus these results support the concept that equine infectious anemia virus is indeed capable of relatively rapid genomic variations during replication, some of which result in altered glycoprotein structures and antigenic variants which are responsible for the unique periodic disease nature observed in persistently infected animals. The findings of envelope specific differences in isolates of visna virus and of human T-cell lymphotropic virus III (acquired immune deficiency syndrome-related virus) suggest that this variation may be a common characteristic of the subfamily Lentivirinae.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research demonstrates that equine infectious anemia virus (EIAV), which is a virus causing infection in horses, presents novel genetic and antigenic variations during the persistence of the infection, resulting in different symptoms in different infectious phases.
Study Background
This study builds on previous findings of the same laboratory which had shown structural variations in the EIAV’s surface proteins and RNA genome during its passage in the host and during chronic infections.
The focus of this particular research was to explore antigenic and biochemical characterization of EIAV recovered from infected ponies experiencing different disease episodes.
Methodology and Findings
For their experiment, the researchers used disease infections in ponies that were separated by intervals of 4 to 8 weeks.
Applying neutralization assays and Western blot analyses, they discovered that the virus isolates could be antigenically differentiated, suggesting that new antigenic variants of EIAV were predominant in each clinical episode.
The researchers observed a structural variation in the virus isolates, citing different electrophoretic mobilities of the viruses’ surface proteins on the sodium dodecyl sulfate-polyacrylamide gels.
Through tryptic peptide and glycopeptide maps of the virus isolates’ proteins, the researchers detected biochemical changes involving alteration in the amino acid sequence and the glycosylation patterns of the virion surface proteins.
However, no structural variation was identified in the internal viral proteins of the virus isolates.
Oligonucleotide mapping experiments revealed unique oligonucleotide fingerprints for each virus isolate’s RNA genome with altered oligonucleotides placed within the predicted env gene region of the genome.
Implications of Findings
The study supports the idea that EIAV can result in considerable genomic variations during replication, causing altered glycoprotein structures and antigenic variants responsible for unique disease characters in persistently infected ponies.
The researchers also hint that variation in envelope-specific differences observed in isolates of visna virus and human T-cell lymphotropic virus III might be a common feature of Lentivirinae, the subfamily to which these viruses belong.
Cite This Article
APA
Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL.
(1986).
Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
J Virol, 57(1), 71-80.
https://doi.org/10.1128/JVI.57.1.71-80.1986
Mullins JI, Casey JW, Nicolson MO, Davidson N. Sequence organization of feline leukemia virus DNA in infected cells.. Nucleic Acids Res 1980 Aug 11;8(15):3287-305.
Bister K, Löliger HC, Duesberg PH. Oligoribonucleotide map and protein of CMII: detection of conserved and nonconserved genetic elements in avian acute leukemia viruses CMII, MC29, and MH2.. J Virol 1979 Oct;32(1):208-19.
Kawaoka Y, Naeve CW, Webster RG. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?. Virology 1984 Dec;139(2):303-16.
Kronvall G, Grey HM, Williams RC Jr. Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins.. J Immunol 1970 Nov;105(5):1116-23.
Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.. Proc Natl Acad Sci U S A 1972 Jun;69(6):1408-12.
Malmquist WA, Barnett D, Becvar CS. Production of equine infectious anemia antigen in a persistently infected cell line.. Arch Gesamte Virusforsch 1973;42(4):361-70.
Pedersen FS, Haseltine WA. Analysis of the genome of an endogenous, ecotropic retrovirus of the AKR strain of mice: micromethod for detailed characterization of high-molecular-weight RNA.. J Virol 1980 Jan;33(1):349-65.
Clements JE, Pedersen FS, Narayan O, Haseltine WA. Genomic changes associated with antigenic variation of visna virus durig persistent infection.. Proc Natl Acad Sci U S A 1980 Aug;77(8):4454-8.
Schmid K, Nimerg RB, Kimura A, Yamaguchi H, Binette JP. The carbohydrate units of human plasma alpha1-acid glycoprotein.. Biochim Biophys Acta 1977 Jun 24;492(2):291-302.
Elder JH, Pickett RA 2nd, Hampton J, Lerner RA. Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein.. J Biol Chem 1977 Sep 25;252(18):6510-5.
Nottay BK, Kew OM, Hatch MH, Heyward JT, Obijeski JF. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans.. Virology 1981 Jan 30;108(2):405-23.
Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.. Anal Biochem 1981 Apr;112(2):195-203.
Massey RJ, Schochetman G. Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization.. Virology 1981 Nov;115(1):20-32.
O'Rear JJ, Temin HM. Spontaneous changes in nucleotide sequence in proviruses of spleen necrosis virus, an avian retrovirus.. Proc Natl Acad Sci U S A 1982 Feb;79(4):1230-4.
Montelaro RC, Lohrey N, Parekh B, Blakeney EW, Issel CJ. Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.. J Virol 1982 Jun;42(3):1029-38.
Thormar H, Barshatzky MR, Arnesen K, Kozlowski PB. The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo.. J Gen Virol 1983 Jul;64 (Pt 7):1427-32.
Darlix JL, Spahr PF. High spontaneous mutation rate of Rous sarcoma virus demonstrated by direct sequencing of the RNA genome.. Nucleic Acids Res 1983 Sep 10;11(17):5953-67.
Shtivelman E, Zakut R, Canaani E. Frequent generation of nonrescuable reorganized Moloney murine sarcoma viral genomes.. Proc Natl Acad Sci U S A 1984 Jan;81(2):294-8.
Bruck C, Rensonnet N, Portetelle D, Cleuter Y, Mammerickx M, Burny A, Mamoun R, Guillemain B, van der Maaten MJ, Ghysdael J. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.. Virology 1984 Jul 15;136(1):20-31.
Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F. Molecular cloning and characterization of the HTLV-III virus associated with AIDS.. Nature 1984 Nov 8-14;312(5990):166-9.
Alexander S, Elder JH. Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens.. Science 1984 Dec 14;226(4680):1328-30.
Gonda MA, Wong-Staal F, Gallo RC, Clements JE, Narayan O, Gilden RV. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.. Science 1985 Jan 11;227(4683):173-7.
Sanchez-Pescador R, Power MD, Barr PJ, Steimer KS, Stempien MM, Brown-Shimer SL, Gee WW, Renard A, Randolph A, Levy JA. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).. Science 1985 Feb 1;227(4686):484-92.
Coffin JM, Champion M, Chabot F. Nucleotide sequence relationships between the genomes of an endogenous and an exogenous avian tumor virus.. J Virol 1978 Dec;28(3):972-91.
Biering SB, Huang A, Vu AT, Robinson LR, Bradel-Tretheway B, Choi E, Lee B, Aguilar HC. N-Glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization. J Virol 2012 Nov;86(22):11991-2002.
Cappelli K, Capomaccio S, Cook FR, Felicetti M, Marenzoni ML, Coppola G, Verini-Supplizi A, Coletti M, Passamonti F. Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus. J Clin Microbiol 2011 Jan;49(1):27-33.
Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 2006 May;80(10):4878-89.
Reinhart TA, Rogan MJ, Amedee AM, Murphey-Corb M, Rausch DM, Eiden LE, Haase AT. Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution. J Virol 1998 Jan;72(1):113-20.
Carvalho M, Kirkland M, Derse D. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J Virol 1993 Nov;67(11):6586-95.
Kilbourne ED, Easterday BC, McGregor S. Evolution to predominance of swine influenza virus hemagglutinin mutants of predictable phenotype during single infections of the natural host. Proc Natl Acad Sci U S A 1988 Nov;85(21):8098-101.
Gebauer F, de la Torre JC, Gomes I, Mateu MG, Barahona H, Tiraboschi B, Bergmann I, de Mello PA, Domingo E. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J Virol 1988 Jun;62(6):2041-9.
Bova CA, Olsen JC, Swanstrom R. The avian retrovirus env gene family: molecular analysis of host range and antigenic variants. J Virol 1988 Jan;62(1):75-83.
Braun MJ, Clements JE, Gonda MA. The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol 1987 Dec;61(12):4046-54.
Le SY, Chen JH, Chatterjee D, Maizel JV. Sequence divergence and open regions of RNA secondary structures in the envelope regions of the 17 human immunodeficiency virus isolates. Nucleic Acids Res 1989 Apr 25;17(8):3275-88.
Steinhauer DA, de la Torre JC, Meier E, Holland JJ. Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol 1989 May;63(5):2072-80.
Gerencer M, Valpotić I, Jukić B, Tomasković M, Basić I. Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS. Arch Virol 1989;104(3-4):249-57.
Bolton V, Pedersen NC, Higgins J, Jennings M, Carlson J. Unique p24 epitope marker to identify multiple human immunodeficiency virus variants in blood from the same individuals. J Clin Microbiol 1987 Aug;25(8):1411-5.
Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol 1987 Feb;61(2):570-8.
Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, Goudsmit J. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol 1990 Aug;64(8):3779-91.
Narayan O. Lentiviruses are etiological agents of chronic diseases in animals and acquired immunodeficiency syndrome in humans. Can J Vet Res 1990 Jan;54(1):42-8.
Rocha E, Cox NJ, Black RA, Harmon MW, Harrison CJ, Kendal AP. Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol 1991 May;65(5):2340-50.
Le Grice SF, Panin M, Kalayjian RC, Richter NJ, Keith G, Darlix JL, Payne SL. Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase. J Virol 1991 Dec;65(12):7004-7.
Chong YH, Payne SL, Issel CJ, Montelaro RC, Rushlow KE. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus. J Virol 1991 Feb;65(2):1007-12.
Holmes EC, Zhang LQ, Simmonds P, Ludlam CA, Brown AJ. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A 1992 Jun 1;89(11):4835-9.
Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjöld ML, Potts B, Murray M, Putney SD, Gray G. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J Virol 1992 Apr;66(4):1875-83.
Perry ST, Flaherty MT, Kelley MJ, Clabough DL, Tronick SR, Coggins L, Whetter L, Lengel CR, Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J Virol 1992 Jul;66(7):4085-97.